- BioViva and Rutgers University announced a collaboration to develop a recombinant mouse cytomegalovirus (R-MCMV) vaccine that expresses multiple anti-aging and regenerative factors, framed as a “vaccine against aging.”  
- A new open-source web tool for CRISPR base editing was shared: https://base-exchanger.herokuapp.com/ allows users to design base-editing experiments.  
- Prellis Biologics launched “Vascular Tissue Blanks™,” off-the-shelf, pre-vascularized 3-D tissue scaffolds intended for complex cell culture and transplantation work.  
- Recent Nature papers and IEEE Spectrum coverage detail the “stentrode,” an endovascular stent-electrode array that can both record and stimulate brain activity via blood vessels, offering a minimally invasive alternative to traditional deep-brain stimulation.  
- A preprint proposes hijacking the secretion systems of brain-infiltrating parasites (e.g., Toxoplasma) to deliver therapeutic proteins across the blood–brain barrier, leveraging the parasite’s natural neuron-targeting ability.  
- AgeX Therapeutics, focused on “cellular immortality and regenerative biology,” began public trading on the NYSE and saw its share price double on the first day.  
- A Nature special issue devoted entirely to gene-therapy advances was noted, underscoring the field’s rapid mainstream momentum.